Motoo Nomura

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 12

Top Topics

Squamous Cell Carcinoma

Combination Therapy

Small Cell Lung Cancer

Top Venues

Esophagus : official journal of the Japan Esophageal Society

Cancer chemotherapy and pharmacology

International journal of clinical oncology

International cancer conference journal

This page only lists publications with an associated author ORCID identifier.

Publications

Motoo Nomura, Taisuke Hosokai, Masashi Tamaoki, Akira Yokoyama, Shigemi Matsumoto, Manabu Muto
Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy. Esophagus : official journal of the Japan Esophageal Society (2023)
Motoo Nomura, Taisuke Hosokai, Masashi Tamaoki, Akira Yokoyama, Shigemi Matsumoto, Manabu Muto
Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy. Esophagus : official journal of the Japan Esophageal Society (2023)
Motoo Nomura, Taisuke Hosokai, Masashi Tamaoki, Akira Yokoyama, Shigemi Matsumoto, Manabu Muto
Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy. Esophagus : official journal of the Japan Esophageal Society (2023)
Motoo Nomura
Definitive treatment for head and neck mucosal melanoma. Japanese journal of clinical oncology (2023)
Motoo Nomura, Taisuke Hosokai, Masashi Tamaoki, Akira Yokoyama, Shigemi Matsumoto, Manabu Muto
Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy. Esophagus : official journal of the Japan Esophageal Society (2023)
Motoo Nomura, Takayuki Kii, Junji Kawada, Masashi Hirota, Takashi Ohta, Jin Matsuyama, Daisuke Sakai, Toshio Shimokawa, Yukinori Kurokawa, Hisato Kawakami, Toshimasa Tsujinaka, Taroh Satoh
A phase II study of S-1 therapy for patients with advanced and recurrent esophageal cancer resistant or intolerable to fluorouracil, platinum, and taxane therapy (OGSG 1404). Esophagus : official journal of the Japan Esophageal Society 19 (4) (2022)
Motoo Nomura, Isao Oze, Toshiki Masuishi, Tomoya Yokota, Hironaga Satake, Shunichiro Iwasawa, Ken Kato, Masashi Andoh
Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma. International journal of clinical oncology 25 (5) (2020)
Takayoshi Komatsu-Fujii, Motoo Nomura, Atsushi Otsuka, Yoshihiro Ishida, Keitaro Doi, Shigemi Matsumoto, Manabu Muto, Kenji Kabashima
Response to imatinib in vaginal melanoma with KIT p.Val559Gly mutation previously treated with nivolumab, pembrolizumab and ipilimumab. The Journal of dermatology 46 (6) (2019)
Takashi Koyama, Motoo Nomura, Doi Keitaro, Ichiro Tateya, Manabu Muto
Re-introducing the same chemotherapy after exposure to anti-PD-1 therapy. International cancer conference journal 8 (2) (2019)
Motoo Nomura, Atsushi Otsuka, Michio Yoshimura, Yumi Nonomura, Yo Kaku, Shigemi Matsumoto, Manabu Muto
Efficacy and safety of concurrent immunoradiotherapy in patients with metastatic melanoma after progression on nivolumab. Cancer chemotherapy and pharmacology 81 (5) (2018)
Motoo Nomura, Atsushi Otsuka, Tomohiro Kondo, Hiroki Nagai, Yumi Nonomura, Yo Kaku, Shigemi Matsumoto, Manabu Muto
Efficacy and safety of retreatment with nivolumab in metastatic melanoma patients previously treated with nivolumab. Cancer chemotherapy and pharmacology 80 (5) (2017)
Motoo Nomura, Isao Oze, Takeshi Kodaira, Tetsuya Abe, Azusa Komori, Yukiya Narita, Toshiki Masuishi, Hiroya Taniguchi, Shigenori Kadowaki, Takashi Ura, Masashi Andoh, Hiroyuki Tachibana, Norihisa Uemura, Masahiro Tajika, Yasumasa Niwa, Manabu Muto, Kei Muro
Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis. International journal of clinical oncology 21 (5) (2016)